Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma

被引:42
作者
Hughes, AM
Armstrong, BK
Vajdic, CM
Turner, J
Grulich, A
Fritschi, L
Milliken, S
Kaldor, J
Benke, G
Kricker, A
机构
[1] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia
[2] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
[3] St Vincents Hosp, Sydney, NSW 2010, Australia
[4] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
[5] St Vincents Hosp, Clin Haematol, Sydney, NSW 2010, Australia
[6] Monash Univ, Dept Epidemiol & Biostat, Melbourne, Vic 3004, Australia
关键词
non-Hodgkin; lymphoma; etiology; sun sensitivity; pigmentary characteristics; case-control study;
D O I
10.1002/ijc.20128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on pigmentary characteristics, sun sensitivity and some other possible risk factors for non-Hodgkin lymphoma (NHL) in people 20-74 years of age. A statewide case-control study was conducted in New South Wales, Australia, with population-based sampling of cases (n = 704) and controls (n = 694). Risk of NHL was increased in subjects with hazel eyes (OR = 1.48; 95% CI = 1.07-2.04), very fair skin (OR = 1.44; 95% CI = 1.01-2.07) and poor ability to tan (OR = 1.70; 95% CI = 1.06-2.71). Risk with mild facial freckling as a child (OR = 0.77; 95% CI = 0.59-0.99) was reduced relative to that with no or moderate to severe freckling. Smokers were not at increased risk of NHL. A past history of treatment for skin cancer was associated with a slight nonsignificant increase in risk. Previous radiotherapy and chemotherapy were associated with 1.5- to 2-fold increases in risk but with wide confidence intervals. These results provide weak support for the possibility that sun sensitivity or perhaps sun exposure increases risk of NHL. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 51 条
[1]   Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time [J].
Abrahamsen, AF ;
Andersen, A ;
Nome, O ;
Jacobsen, AB ;
Holte, H ;
Abrahamsen, JF ;
Kvaloy, S .
ANNALS OF ONCOLOGY, 2002, 13 (11) :1786-1791
[2]   2ND MALIGNANCIES AFTER TREATMENT OF HODGKINS-DISEASE - THE INFLUENCE OF TREATMENT, FOLLOW-UP TIME, AND AGE [J].
ABRAHAMSEN, JF ;
ANDERSEN, A ;
HANNISDAL, E ;
NOME, O ;
ABRAHAMSEN, AF ;
KVALOY, S ;
HOST, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :255-261
[3]   EVIDENCE OF AN ASSOCIATION BETWEEN NON-HODGKINS-LYMPHOMA AND SKIN-CANCER [J].
ADAMI, J ;
FRISCH, M ;
YUEN, J ;
GLIMELIUS, B ;
MELBYE, M .
BRITISH MEDICAL JOURNAL, 1995, 310 (6993) :1491-1495
[4]   Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden) [J].
Adami, J ;
Nyren, O ;
Bergstrom, R ;
Ekbom, A ;
Engholm, G ;
Englund, A ;
Glimelius, B .
CANCER CAUSES & CONTROL, 1998, 9 (01) :49-56
[5]   The epidemiology of UV induced skin cancer [J].
Armstrong, BK ;
Kricker, A .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 63 (1-3) :8-18
[6]  
Australian Bureau of Statistics, 1998, SOC IND AR
[7]   NON-HODGKINS-LYMPHOMA ARISING IN PATIENTS TREATED FOR HODGKINS-DISEASE IN THE BNLI - A 20-YEAR EXPERIENCE [J].
BENNETT, MH ;
MACLENNAN, KA ;
HUDSON, GV ;
HUDSON, BV .
ANNALS OF ONCOLOGY, 1991, 2 :83-92
[8]  
Bentham G, 1996, BRIT MED J, V312, P1128
[9]   CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J].
BIRKELAND, SA ;
STORM, HH ;
LAMM, LU ;
BARLOW, L ;
BLOHME, I ;
FORSBERG, B ;
EKLUND, B ;
FJELDBORG, O ;
FRIEDBERG, M ;
FRODIN, L ;
GLATTRE, E ;
HALVORSEN, S ;
HOLM, NV ;
JAKOBSEN, A ;
JORGENSEN, HE ;
LADEFOGED, J ;
LINDHOLM, T ;
LUNDGREN, G ;
PUKKALA, E .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) :183-189
[10]   RISK OF CUTANEOUS MELANOMA-ASSOCIATED WITH PIGMENTATION CHARACTERISTICS AND FRECKLING - SYSTEMATIC OVERVIEW OF 10 CASE-CONTROL STUDIES [J].
BLISS, JM ;
FORD, D ;
SWERDLOW, AJ ;
ARMSTRONG, BK ;
CRISTOFOLINI, M ;
ELWOOD, JM ;
GREEN, A ;
HOLLY, EA ;
MACK, T ;
MACKIE, RM ;
OSTERLIND, A ;
WALTER, SD ;
PETO, J ;
EASTON, DF .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) :367-376